Arul Mahadevan MD FRCS, Dip ABLM

Benign Diseases, Sarcoma, Urologic Cancer

Medical Director, Mass General Brigham Cancer Institute

789 Central AveSeacost Cancer CenterDover, NH 03820
Phone+1 603-742-8787
Fax+1 603-740-2637

Dr. Mahadevan is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Mahadevan's full profile Already have an account?

Summary

Dr. Arul Mahadevan is Medical Director of the Mass General Brigham Cancer Institute based in Dover, NH, specializing in Urologic Cancer. He completed his residency in Radiation Oncology at McGaw Medical Center of Northwestern University. Dr. Mahadevan currently serves as the Medical Director at Mass General Brigham Cancer Institute and has experience as a Radiation Oncologist at Cleveland Clinic. His expertise includes renal cell carcinoma, radiosurgery, and prostate cancer, among others. He has authored publications in Practical Radiation Oncology and the International Journal of Radiation Oncology, Biology, Physics. He has also been involved in clinical trials focusing on stereotactic radiosurgery and radiation therapy in treating metastases and musculoskeletal malignancies. He is Board Certified in Lifestyle Medicine and incorporates Lifestyle Interventions in cancer care, recovery and prevention.

Education & Training

McGaw Medical Center of Northwestern UniversityResidency, Radiation Oncology, 1998 - 2002
Kilpauk Medical CollegeClass of 1988

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

NH State Medical License 2008 - 2028
MA State Medical License 2008 - 2027
OH State Medical License 2002 - 2026
WA State Medical License 2021 - 2026
MN State Medical License 2021 - 2023
IL State Medical License 1998 - 2005
American Board of Radiology Radiation Oncology
Royal College of Surgeons of EdinburghFRCS Ed

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification Allscripts Enterprise EHR (Complete), Allscripts, 2013-2014, 2017
CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2013-2014, 2017
CMS Meaningful Use Stage 2 Certification Beacon Oncology 2014 Certified Module, Epic Systems Corporation, 2013-2014, 2017

Clinical Trials

Stereotactic Radiation Therapy With or Without Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases
COMPLETED
PHASE3
Temozolomide and Radiation Therapy With or Without Bevacizumab in Treating Patients With Newly Diagnosed Glioblastoma Start of enrollment: 2009 Apr 15
COMPLETED
PHASE3
Image-Guided Radiosurgery or Stereotactic Body Radiation Therapy in Treating Patients With Localized Spine Metastasis
COMPLETED
PHASE2, PHASE3

Publications & Presentations

PubMed

1 citations
Dramatic Improvement of Antitranscription Intermediary Factor-1-γ/α Antibody-Positive Dermatomyositis After Stereotactic Body Radiation Therapy to Presumed Lung Primar...
Aleksandra Kuczmarska-Haas, Adam R. Burr, Jacob S. Witt, David M. Francis, Hagger Ali
Practical Radiation Oncology. 2020-07-02
19 citations
Causes of Mortality After Dose-Escalated Radiation Therapy and Androgen Deprivation for High-Risk Prostate Cancer
Rahul D. Tendulkar, G.K. Hunter, Chandana A. Reddy, Kevin L. Stephans, Jay P. Ciezki
International Journal of Radiation Oncology, Biology, Physics. 2013-09-01
33 citations
Intraoperative radiation therapy with the photon radiosurgery system in locally advanced and recurrent rectal cancer: retrospective review of the Cleveland clinic expe...
S. Guo, Chandana A. Reddy, Matthew D. Kolar, Neil M. Woody, Arul Mahadevan
Radiation Oncology. 2012-07-20

Lectures

Radiation Oncology Mock Oral
The Osler Institute, Louisville, Kentucky - 6/6/2013
Radiation Oncology Review
The Osler Institute, Louisville, Kentucky - 6/5/2013
Radiation Oncology (Biology and Physics)
The Osler Institute, Louisville, Kentucky - 6/2/2013